Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Mizrahi, R. Articles by Kapur, S. Search for Related Content PubMed Citation Articles by Mizrahi, R. Articles by Kapur, S. Schizophrenia Spectrum Disorders Atypical Neuroleptics PET

Adverse Subjective Experience With Antipsychotics and Its Relationship to Striatal and Extrastriatal D₂ Receptors: a PET Study in Schizophrenia

OBJECTIVES:Antipsychotic medications improve psychosis but often induce a state of dysphoria in patients. Blockade of the dopamine D₂ receptors, which is thought to mediate their efficacy, has also been implicated in producing this adverse subjective experience. The authors present the first double-blind controlled study to examine the relationship between striatal and extrastriatal dopamine D₂ receptor binding potential and occupancy values and adverse subjective experience. METHOD: Patients with recent-onset psychosis (N=12) were randomly assigned to low or high doses of olanzapine or risperidone. Subjective experiences, motor side effects, and striatal and extrastriatal dopamine D₂ receptors (determined with ([ ¹¹C]raclopride and [ ¹¹C]FLB 457 PET scans, respectively) were evaluated after 2 weeks of continuous antipsychotic treatment. RESULTS: Higher dopamine D₂ receptor occupancy and binding potentials in the striatal (dorsal and ventral), temporal, and insular regions were associated with subjective experience. The finding was confirmed with two convergent methods of analysis (region-of-interest and voxel-based statistics), and the same relationship was observed using two different dopamine receptor measures (observed binding potential values and age- and sex-corrected occupancy values). CONCLUSIONS: Higher D₂ receptor occupancy is associated with negative subjective experience in patients taking risperidone or olanzapine. These negative subjective effects may be related to the high discontinuation rates seen in usual practice. Understanding the neurobiological mechanism of these negative subjective experiences and developing antipsychotics with novel (i.e., non D₂) mechanisms may be critical in improving the treatment of psychosis.

This article has been cited by other articles:

				A. T. Knoll, E. G. Meloni, J. B. Thomas, F. I. Carroll, and W. A. Carlezon Jr. Anxiolytic-Like Effects of {kappa}-Opioid Receptor Antagonists in Models of Unlearned and Learned Fear in Rats J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 838 - 845. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2007 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us